about
Transfer of efficient anti-melanocyte T cells from vitiligo donors to melanoma patients as a novel immunotherapeutical strategyConcise review of recent studies in vitiligoToxicity profile of approved anti-PD-1 monoclonal antibodies in solid tumors: a systematic review and meta-analysis of randomized clinical trialsGenome-wide association study of generalized vitiligo in an isolated European founder population identifies SMOC2, in close proximity to IDDM8Mechanisms of spatial and temporal development of autoimmune vitiligo in tyrosinase-specific TCR transgenic mice.Vitiligo in adults and children.Identification of peptides specific for antibodies in vitiligo using a phage library.Dermatosurgical techniques for repigmentation of vitiligo.Vitiligo puzzle: the pieces fall in place.Vitiligo.Combination immunotherapy for high-risk resected and metastatic melanoma patientsDepigmentation therapies for normal skin in vitiligo universalis.Increased Risk of Metabolic Syndrome in Patients with Vitiligo.Impact of HLA-G in the outcome of vitiligo in Tunisian patientsCTLA-4 A49G gene polymorphism is not associated with vitiligo in South Indian population.Association of CYP2C9 Genetic Variants with Vitiligo.Th17 cells and activated dendritic cells are increased in vitiligo lesionsA novel linkage to generalized vitiligo on 4q13-q21 identified in a genomewide linkage analysis of Chinese families.Keratinocyte-derived laminin-332 protein promotes melanin synthesis via regulation of tyrosine uptake.Photo(chemo)therapy for vitiligo.Shared genetic relationships underlying generalized vitiligo and autoimmune thyroid disease.Vulvar vitiligo-like depigmentation and multiple halos of hypomelanosis at the trunk following treatment with imiquimod 5% cream for vulvar condylomata: casual or related events?A critical appraisal of vitiligo etiologic theories. Is melanocyte loss a melanocytorrhagy?Koebner's phenomenon in vitiligo: European position paper.Dermal mesenchymal stem cells (DMSCs) inhibit skin-homing CD8+ T cell activity, a determining factor of vitiligo patients' autologous melanocytes transplantation efficiency.Reduced serum brain-derived neurotrophic factor in patients with first onset vitiligo.Association between Vitiligo and Thyroid Autoimmunity.Amniotic membrane as a scaffold for melanocyte transplantation in patients with stable vitiligo.Vitiligo in adults and children: surgical interventions.Serum concentration of IL-6, IL-2, TNF-α, and IFNγ in Vitiligo patientsPediatric Patients with Vitiligo in Eastern China: Abnormalities in 145 Cases Based on Thyroid Function Tests and Immunological FindingsRecent progress in the genetics of generalized vitiligo.CD8+ T cells from vitiligo perilesional margins induce autologous melanocyte apoptosis.Aire deficiency promotes TRP-1-specific immune rejection of melanoma.HSP70i is a critical component of the immune response leading to vitiligoTargeted Broadband UVB Phototherapy forthe Treatment of Localized Vitiligo.Systemic analyses of immunophenotypes of peripheral T cells in non-segmental vitiligo: implication of defective natural killer T cells.Prevalence of thyroid function test abnormalities and thyroid autoantibodies in children with vitiligo.Thyroid dysfunction and thyroid antibodies in Iranian patients with vitiligo.Vitiligo blood transcriptomics provides new insights into disease mechanisms and identifies potential novel therapeutic targets.
P2860
Q24814910-9223A6E5-12C7-4843-AAE3-7CE75B43E30FQ27025963-C57EF669-FCD6-4FE2-A490-C23C21BBAAE4Q28067583-2035153B-7EAF-46DE-8F4F-A8F55B43694BQ28943256-3CB10A42-CBBC-4ACD-B129-3944FDEB06F7Q30433217-AA31C22C-C34B-4E43-94D5-81EF60BDD52CQ31004500-40E65EA3-F7BB-435A-A5B2-E8A7B71C69A1Q33224361-D303FEF8-1679-4A72-8CBF-CC04B4A6687DQ33241634-C995BA12-8FA7-40FA-8640-E5105A718996Q33344607-4CE8FB2C-67D5-44B3-9BEA-B5BC5427D5DAQ33446628-4AB525EE-EBA5-4757-A6BC-10E279C39C83Q33737498-F7BC060A-8FA5-464C-B21D-C6EFBE4D7793Q33739817-EAF83E1E-56A0-4E10-87B0-73409C508F3AQ33745258-FF34DB3B-276E-4D50-93EE-7C95E8808BAEQ33796649-10F82BA6-1A78-4AF2-9D75-0201DD8C1A38Q33796655-0147E7EF-DF2C-4C38-B998-678CA658A470Q33801991-C9B79777-C915-47B1-A1D0-9F253AF8CCC7Q33889471-72A82ED5-625F-4376-ACAB-62D84843C797Q33938843-88BAEFBB-E425-49D3-9422-3820691F8741Q33985411-DA8FBDAA-BFE1-4FA4-A486-F9BDA2E067BAQ34032268-6100D8F1-7BF9-49F7-B0EA-0A1C6C1855B5Q34110126-5A433B78-9616-48BB-A0A7-EC785AAC2885Q34140536-55B53414-948C-4131-9D05-B54232490836Q34535453-B86DE7C5-3446-4256-9B1E-7F91A777F530Q34626993-435DE593-712C-4E68-A8EF-C9DD28966543Q34663693-0C540CC4-CE92-4EB3-82E9-4EC6CDB04AE3Q34731431-DC90E617-AE88-47A7-9CFA-A1E83B1DF21DQ35062131-22B0CC84-6DC7-4E93-936F-F2EDDEB5596DQ35173306-AF1CA61F-E2FE-48F1-800D-C0F0CB9AE745Q35584658-8108D8B9-11D2-4670-B06B-DFDE0228CBBDQ35853718-C6882353-2F37-4EB9-ABBF-387AF3B2AE54Q36232253-C86A2293-418D-433D-99D5-3F45CDD58E9EQ36441780-0AC16672-BBC0-44BE-A298-1456E9951805Q36610648-11AE9866-4525-40F1-917C-83D7A33BA752Q36745323-EB64A44E-11A8-4266-860A-A5953AFFDF1EQ36871508-E33281AF-365C-4B9D-BE78-EEB9584447D2Q36995590-4C473F16-6D23-4236-83D3-D3180149F99BQ37240967-5AB5237B-078D-432A-9CAB-8EFA912E845DQ37413965-14A79686-4F49-4020-BFB7-5559FD04EE30Q37443903-78F899CD-1844-43E1-8513-BB64C108E306Q37611016-9C98A5BF-6F9B-4714-941B-79DB4F4476B1
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Evidence for an autoimmune pathogenesis of vitiligo.
@ast
Evidence for an autoimmune pathogenesis of vitiligo.
@en
type
label
Evidence for an autoimmune pathogenesis of vitiligo.
@ast
Evidence for an autoimmune pathogenesis of vitiligo.
@en
prefLabel
Evidence for an autoimmune pathogenesis of vitiligo.
@ast
Evidence for an autoimmune pathogenesis of vitiligo.
@en
P2093
P2860
P1476
Evidence for an autoimmune pathogenesis of vitiligo.
@en
P2093
Jean-Marie Naeyaert
Katia Ongenae
Nanny Van Geel
P2860
P304
P356
10.1034/J.1600-0749.2003.00023.X
P577
2003-04-01T00:00:00Z